Vastagbélrák: vizsgálatok itt: Japán
47 trials · From ClinicalTrials.gov, checked 2026. november 12.. Ask the study team whether a trial fits you.
- 2. fázisTaking peopleStudy to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors
- Where
- Kashiwa
- Életkor
- 18 év and over
- People
- 430 worldwide
- Run by
- Pfizer
See details and how to joinNCT04557449 · EU 2024-512120-11-00 - 1/2. fázisTaking peopleBeamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
- Where
- Aichi, Nagoya, Isehara, Kagoshima, Kanagawa, Yokohama, Kashiwa-shi, Kyoto, Osaka, Tokyo, Koto-ku
- Életkor
- 18 év and over
- People
- 910 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT06324357 - 3. fázisTaking peoplePhase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
- Where
- Aichi, Chiba, Ehime, Fukuoka, Gifu, Hiroshima, Hokkaido, Kawasaki, Osaka, Saitama, Sendai, Shizuoka, Tokyo, Toyama, Yokohama
- Életkor
- 18 év and over
- People
- 900 worldwide
- Run by
- Summit Therapeutics
See details and how to joinNCT07228832 - 3. fázisTaking peopleA Study of Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal Cancer (PROCEADE-CRC-03)
- Where
- Chūōku, Fukuoka, Kitaadachi-gun, Kōtoku, Nagoya, Osaka, Sakai-shi, Sunto, Yokohama
- Életkor
- 18 év and over
- People
- 1020 worldwide
- Run by
- EMD Serono Research & Development Institute, Inc.
See details and how to joinNCT07549412 · EU 2025-524648-37-00 - 1. fázisTaking peopleA Study of Sofe-M in Participants With Selected Advanced Solid Tumors
- Where
- Shizuoka, Tokyo
- Életkor
- 18 év and over
- People
- 575 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT06400472 · EU 2024-511238-11-00 - 2. fázisTaking peopleA Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
- Where
- Chuo Ku, Kashiwa, Koto-ku, Nagoya, Sakai, Sapporo
- Életkor
- 18 év and over
- People
- 111 worldwide
- Run by
- Bayer
See details and how to joinNCT06760819 · EU 2024-517419-62-00 - 3. fázisTaking peopleA Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
- Where
- Bunkyo, Chiba, Chūō, Fukuoka, Hidaka, Kashiwa, Kitaadachi-gun, Kita-gun, Koto, Nagoya, Osaka, Sakai, Sapporo, Sendai, Sunto-gun, Yokohama
- Életkor
- 18 év and over
- People
- 477 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06997497 · EU 2024-517232-22-00 - 1. fázisTaking peopleA Study of LY4257496 in Participants With Cancer (OMNIRAY)
- Where
- Chiba, Kyoto, Osaka
- Életkor
- 18 év and over
- People
- 421 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07114601 · EU 2025-522367-15-00 - 1. fázisTaking peopleA Study of LY4337713 in Participants With FAP-Positive Solid Tumors
- Where
- Chiba, Kyoto
- Életkor
- 18 év and over
- People
- 340 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07213791 · EU 2025-521887-37-00 - 3. fázisTaking peopleA Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
- Where
- Chiba, Chūōku, Kashiwa, Nagoya, Osaka, Shizuoka, Suita, Tokyo
- Életkor
- 18 év and over
- People
- 1000 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT06662786 · EU 2024-513852-13-00 - 3. fázisTaking peopleA Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
- Where
- Chiba, Chūōku, Kashiwa, Nagoya, Osaka, Sakai, Shizuoka, Suita, Tokyo
- Életkor
- 18 év and over
- People
- 700 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT06750094 · EU 2024-513853-66-00 - 3. fázisTaking peopleA Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
- Where
- Akashi-shi, Chiba, Chūōku, Fukuoka, Hidaka-shi, Kashiwa-shi, Kawasaki-shi, Kitaadachi-gun, Kita-gun, Kobe, Kōtoku, Kurashiki-shi, Nankoku-shi, Osaka, Shizuoka, Suita-shi, Yokohama
- Életkor
- 18 év and over
- People
- 700 worldwide
- Run by
- Incyte Corporation
See details and how to joinNCT07284849 · EU 2025-523735-19-00 - 1/2. fázisTaking peopleA Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)
- Where
- Kashiwa, Yokohama
- Életkor
- 18 év and over
- People
- 220 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06428409 · EU 2023-508703-21-00 - 1. fázisTaking peopleA Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
- Where
- Hirakata, Koto-Ku
- Életkor
- 18 év and over
- People
- 404 worldwide
- Run by
- Astellas Pharma Inc
See details and how to joinNCT07094204 · EU 2025-522082-29-00 - 2. fázisTaking peopleA Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer
- Where
- Chuo-Ku, Kashiwa-shi, Kawasaki-shi, Nagoya, Sendai
- Életkor
- 18 év and over
- People
- 390 worldwide
- Run by
- AbbVie
See details and how to joinNCT06820463 · EU 2024-512981-33-00 - 1/2. fázisTaking peopleA Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
- Where
- Chuo Ku, Kashiwa, Koto-ku, Matsuyama, Nagaizumi-chō, Nagoya, Ōsaka-sayama, Saitama
- Életkor
- 18 év and over
- People
- 680 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06330064 · EU 2023-509632-26-00 - 2/3. fázisTaking peopleA Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
- Where
- Chiba, Chuo Ku, Fukuoka, Hidaka, Ina-machi, Kashiwa, Kobe, Koto-ku, Kurashiki, Matsuyama, Nagaizumi-cho,Sunto-gun, Nagoya, Osaka, Sapporo, Sendai, Suita, Takatsuki, Toyoake, Yamagata, Yokohama
- Életkor
- 18 év and over
- People
- 990 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07221357 · EU 2025-523224-45-00 - No phaseTaking peopleTheraSphere Japan Pre-Market Study
- Where
- Chuo Ku, Kanazawa, Kashihara, Nishinomiya, Sayama
- Életkor
- 18 év and over
- People
- 51
- Run by
- Boston Scientific Corporation
See details and how to joinNCT07377487 - 1/2. fázisTaking peopleA Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advanced Gastrointestinal Cancers That Cannot be Surgically Removed (EMBOLD PanGI-201)
- Where
- Aichi, Chiba, Hokkaido, Osaka, Tokyo
- Életkor
- 18 év and over
- People
- 346 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT06885034 - 3. fázisTaking peopleA Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal Cancer
- Where
- Kashiwa-shi, Kawasaki-shi, Kobe, Koto-ku, Matsuyama, Osaka
- Életkor
- 18 év and over
- People
- 990 worldwide
- Run by
- AbbVie
See details and how to joinNCT07525206 · EU 2025-521712-19-00 - 1/2. fázisTaking peoplePhase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
- Where
- Kanagawa, Kyoto, Tokyo
- Életkor
- 18 év and over
- People
- 554 worldwide
- Run by
- Institut de Recherches Internationales Servier
See details and how to joinNCT05786924 · EU 2025-523474-16-00 - 2. fázisTaking peopleA Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
- Where
- Fukuoka, Gifu, Kashiwa-shi, Nagoya, Osaka, Sendai, Sunto-gun, Yokohama
- Életkor
- 18 év and over
- People
- 140 worldwide
- Run by
- AbbVie
See details and how to joinNCT07023289 · EU 2024-518015-19-00 - 3. fázisTaking peopleSymbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
- Where
- Chiba, Fukuoka, Hidaka, Kashiwa, Kitaadachi-Gun, Koto-ku, Nagaizumi-chō, Nagoya, Osaka, Yokohama
- Életkor
- 18 év and over
- People
- 800 worldwide
- Run by
- Pfizer
See details and how to joinNCT07222800 · EU 2025-523521-18-00 - 2. fázisTaking peopleStudy of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
- Where
- Chūōku, Kashiwa, Kōtoku, Nagoya, Shinagawa-ku, Suita-shi
- Életkor
- 18 év to 130 év
- People
- 454 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT05489211 · EU 2023-509436-26-00 - 1/2. fázisTaking peopleA Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
- Where
- Chuo Ku, Kashiwa-shi, Koto-ku
- Életkor
- 18 év and over
- People
- 150 worldwide
- Run by
- Astellas Pharma Global Development, Inc.
See details and how to joinNCT07488676